Table: Sapporo Clinical Lab -2015/16 parent results
May 13 (Reuters)-
Sapporo Clinical Laboratory Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2016 Mar 31, 2015 Mar 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 16.27 15.74 16.28 8.12
(+3.4 pct) (+3.5 pct) (+0.0 pct) (+1.2 pct)
Operating 933 mln 833 mln
(+11.9 pct) (-5.8 pct)
Recurring 961 mln 865 mln 681 mln 363 mln
(+11.0 pct) (-5.6 pct) (-29.1 pct) (-27.6 pct)
Net 569 mln 559 mln 448 mln 240 mln
(+1.9 pct) (+13.7 pct) (-21.3 pct) (-24.6 pct)
EPS 163.80 yen 147.23 yen 128.97 yen 69.04 yen
-Q2 Div NIL NIL NIL
-Q4 Div 11.00 yen 12.00 yen 11.00 yen
NOTE - Sapporo Clinical Laboratory Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Sapporo Clinical Laboratory
See all newsTable: Sapporo Clinical Lab - 9-MTH group results
Table: Sapporo Clinical Lab - 6-MTH group results
Brief: Sapporo Clinical Laboratory Inc - To Retire Treasury Shares Worth 26% Of Outstanding Stock On Feb 17
Table: Sapporo Clinical Lab -Q1 group results
Table: Sapporo Clinical Lab -2024/25 parent results